With the first half of 2026 behind us, we recently reflected on the past three months of the year and all the valuable guidance we’ve seen published by North American and international societies across all medical specialties. Now, with six months still to go in 2026, we are taking a look ahead to some clinical guidelines and guidance that we anticipate will publish by the end of the year.
The following list features two key specialties that we identified as having the largest grouping of anticipated publications: oncology and cardiology. Links are provided to current versions where appropriate. All provided dates are our best estimates.
Most Anticipated Cardiology Guidance for Q3, Q4 2026
- Primary Prevention Cardiovascular Disease
- American College of Cardiology (ACC) /American Heart Association (AHA)
- Q4 2026
- Current Version
- Resistant Hypertension Monitoring and Management
- American College of Cardiology (ACC)
- Q3 2026
- Lipid Lowering Strategies in the Era of Early Atherosclerosis Detection
- American College of Cardiology (ACC)
- Q3 2026
- Management of Heart Failure with Preserved Ejection Fraction
- American College of Cardiology (ACC)
- Q3 2026
- Current Version
- ACC - The Role of Nonstatin Lipid Lowering Therapies in ASCVD Risk Management
- American College of Cardiology (ACC)
- Q4 2026
- Current Version
Most Anticipated Oncology Guidance for Q3, Q4 2026
- Breast Cancer Follow-Up After Primary Treatment
- American Society of Clinical Oncology (ASCO)
- Q3 2026
- Medical Therapy for Hormone Receptor Positive, HER2-Negative Stage I-III Breast Cancer
- American Society of Clinical Oncology (ASCO)
- Q3 2026
- Differentiated Thyroid Cancer - Thyroid Nodules
- American Thyroid Association (ATA)
- November 2026
- Current Version
- Medullary Thyroid Cancer
- American Thyroid Association (ATA)
- 2026
- Current Version
- AAD - Management of Melanoma
- American Academy of Dermatology (AAD)
- Q4 2026
- Current Version
- Hypofractionated Radiation Therapy for Localized Prostate Cancer
- American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) / American Urological Association (AUA)
Q3 2026 - Current Version
- American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) / American Urological Association (AUA)
- Radiation Therapy for Endometrial Cancer
- American Society for Radiation Oncology (ASTRO) / American Brachytherapy Society (ABS) / American Society of Clinical Oncology (ASCO) / Society of Gynecologic Oncology (SGO)
- Q3/Q4 2026
- Current Version
- Diagnosis and Staging of Non-Small Cell Lung Cancer
- American College of Chest Physicians (CHEST)
- 2026
- Current Version
- Radiation Therapy for Pancreatic Cancer
- American Society for Radiation Oncology (ASTRO) / American Sosicet of Clinical Oncology (ASCO) / Society of Surgical Oncology (SSO)
- Q3/Q4 2026
- Current Version
Sign up for alerts to stay informed on the latest published guidelines and articles.
